The present invention pertains to Benzyl-substituted tetracyclic heterocyclic compounds, as well as the resulting pharmaceutical compositions, and their use in the treatment or prophylaxis of diseases alleviated by inhibition of type 5 phosphodiesterases. Furthermore, the present invention pertains to the methods of manufacturing these Benzyl-substituted tetracyclic heterocyclic compounds.
本发明涉及苄基取代的四环
杂环化合物,以及由此产生的药物组合物,以及它们在治疗或预防通过抑制第5型
磷酸二酯酶缓解的疾病中的应用。此外,本发明涉及制造这些苄基取代的四环
杂环化合物的方法。